NCT02115529View on ClinicalTrials.gov

Study of Prevention of Postoperative Nausea and Vomiting Using Cesamet

PHASE2CompletedINTERVENTIONAL
Enrollment

331

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

November 30, 2015

Conditions
Postoperative Nausea and Vomiting
Interventions
DRUG

Nabilone

Nabilone (0.5 mg) or placebo given preoperatively

DRUG

Placebo

Placebo Comparator: identical capsule containing placebo (single dose) given preoperatively

Trial Locations (1)

M5B 1W8

St Michael's Hospital, Toronto

All Listed Sponsors
lead

Unity Health Toronto

OTHER

NCT02115529 - Study of Prevention of Postoperative Nausea and Vomiting Using Cesamet | Biotech Hunter | Biotech Hunter